IRCT20240224061097N1招募中3 期
Comparison between prophylactic antiemetic effects of Ondansetron and Haloperidol patients undergoing mastectomy- double-blind clinical trial
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 35 years 至 60 years（—）
- 性别
- All
入选标准
- •All candidate patients for bilateral mastectomy 2 side
- •ASA class 1 and 2 patients
- •All patients with general anesthesia
- •Patients aged 35-60.
排除标准
- •Duration of surgery more than 150 minutes
- •Parkinson's disease
- •Patients with a history of psychiatric disorders
- •History of chemotherapy and radiation therapy
- •History of nausea and vomiting in previous surgeries
- •Having a movement disorder patient with a history of malignancy
- •Patients with prolonged QT interval
- •Use of opioids, sedatives, or any type of analgesic within one week before mastectomy History of alcohol consumption
- •History of drug abuse
研究者
相似试验
已完成
不适用
Comparison of antiemetic effectiveness and safety of palonosetron and dexamethasone with palonosetron, dexamethasone and aprepitant in patients with lung cancer receiving combination therapy with carboplatin: A phase II randomized studylung cancerJPRN-UMIN000010056Hamamatsu University School of Medicine80
已完成
不适用
The effectiveness of prophylactic antiemetics 'syouhangekabukuryouto' on postoperative nausea and vomiting patientswomen who will receive laparoscopic gynecologic surgeryJPRN-UMIN000018381Saiseikai Central Hospital20
招募中
不适用
Study of the relationship between antiemetic effect of aprepitrant and genetic polymorphism of ABC transporterJPRN-UMIN000004910Department of Clinical Pharmacology and Genitics, School of Pharmaceutical Science, Univercity of Shizuoka100
招募中
不适用
Comparitive study of two antiemetic drugs group to decrease the chances of emesis after Laproscopic CholecyestectomyCTRI/2018/07/014830Dr RPGMC TANDA84
已完成
2 期
Clinical evaluation of two antiemetic combinations palonosetron dexamethazone in paclitaxel and carboplatin: a randomized phase II trial.patients with gynecological malignancies who are receiving paclitaxel/carboplatin.JPRN-UMIN000007491ara Medical University80